316 related articles for article (PubMed ID: 32006383)
21. Exploring Shared Pathogenesis of Alzheimer's Disease and Type 2 Diabetes Mellitus via Co-expression Networks Analysis.
Zhu Y; Ding X; She Z; Bai X; Nie Z; Wang F; Wang F; Geng X
Curr Alzheimer Res; 2020; 17(6):566-575. PubMed ID: 32781959
[TBL] [Abstract][Full Text] [Related]
22. Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach.
Hu YS; Xin J; Hu Y; Zhang L; Wang J
Alzheimers Res Ther; 2017 Apr; 9(1):29. PubMed ID: 28446202
[TBL] [Abstract][Full Text] [Related]
23. Intrinsic-overlapping co-expression module detection with application to Alzheimer's Disease.
Manners HN; Roy S; Kalita JK
Comput Biol Chem; 2018 Dec; 77():373-389. PubMed ID: 30466046
[TBL] [Abstract][Full Text] [Related]
24. Integrated analysis of differential gene expression profiles in hippocampi to identify candidate genes involved in Alzheimer's disease.
Hu W; Lin X; Chen K
Mol Med Rep; 2015 Nov; 12(5):6679-87. PubMed ID: 26324066
[TBL] [Abstract][Full Text] [Related]
25. Identification of Electrophysiological Changes in Alzheimer's Disease: A Microarray Based Transcriptomics and Molecular Pathway Analysis Study.
Mirza Z; Rajeh N
CNS Neurol Disord Drug Targets; 2017; 16(9):1027-1038. PubMed ID: 29065845
[TBL] [Abstract][Full Text] [Related]
26. 5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer's disease modulate Tau-induced neurotoxicity.
Bernstein AI; Lin Y; Street RC; Lin L; Dai Q; Yu L; Bao H; Gearing M; Lah JJ; Nelson PT; He C; Levey AI; Mullé JG; Duan R; Jin P
Hum Mol Genet; 2016 Jun; 25(12):2437-2450. PubMed ID: 27060332
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profile and functional analysis of Alzheimer's disease.
Chen F; Guan Q; Nie ZY; Jin LJ
Am J Alzheimers Dis Other Demen; 2013 Nov; 28(7):693-701. PubMed ID: 24005853
[TBL] [Abstract][Full Text] [Related]
28. Identification of Hub Genes Related to Alzheimer's Disease and Major Depressive Disorder.
Cheng Y; Sun M; Wang F; Geng X; Wang F
Am J Alzheimers Dis Other Demen; 2021; 36():15333175211046123. PubMed ID: 34732058
[TBL] [Abstract][Full Text] [Related]
29. Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease.
Talwar P; Silla Y; Grover S; Gupta M; Agarwal R; Kushwaha S; Kukreti R
BMC Genomics; 2014 Mar; 15(1):199. PubMed ID: 24628925
[TBL] [Abstract][Full Text] [Related]
30. An integrated brain-specific network identifies genes associated with neuropathologic and clinical traits of Alzheimer's disease.
Lin CX; Li HD; Deng C; Liu W; Erhardt S; Wu FX; Zhao XM; Guan Y; Wang J; Wang D; Hu B; Wang J
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34953465
[TBL] [Abstract][Full Text] [Related]
31. Common dysregulation network in the human prefrontal cortex underlies two neurodegenerative diseases.
Narayanan M; Huynh JL; Wang K; Yang X; Yoo S; McElwee J; Zhang B; Zhang C; Lamb JR; Xie T; Suver C; Molony C; Melquist S; Johnson AD; Fan G; Stone DJ; Schadt EE; Casaccia P; Emilsson V; Zhu J
Mol Syst Biol; 2014 Jul; 10(7):743. PubMed ID: 25080494
[TBL] [Abstract][Full Text] [Related]
32. Identifying Blood Transcriptome Biomarkers of Alzheimer's Disease Using Transgenic Mice.
Ochi S; Iga JI; Funahashi Y; Yoshino Y; Yamazaki K; Kumon H; Mori H; Ozaki Y; Mori T; Ueno SI
Mol Neurobiol; 2020 Dec; 57(12):4941-4951. PubMed ID: 32816243
[TBL] [Abstract][Full Text] [Related]
33. Altered sphingolipid function in Alzheimer's disease; a gene regulatory network approach.
Giovagnoni C; Ali M; Eijssen LMT; Maes R; Choe K; Mulder M; Kleinjans J; Del Sol A; Glaab E; Mastroeni D; Delvaux E; Coleman P; Losen M; Pishva E; Martinez-Martinez P; van den Hove DLA
Neurobiol Aging; 2021 Jun; 102():178-187. PubMed ID: 33773368
[TBL] [Abstract][Full Text] [Related]
34. Bayesian integrative analysis of epigenomic and transcriptomic data identifies Alzheimer's disease candidate genes and networks.
Klein HU; Schäfer M; Bennett DA; Schwender H; De Jager PL
PLoS Comput Biol; 2020 Apr; 16(4):e1007771. PubMed ID: 32255787
[TBL] [Abstract][Full Text] [Related]
35. A comprehensive analysis on preservation patterns of gene co-expression networks during Alzheimer's disease progression.
Ray S; Hossain SMM; Khatun L; Mukhopadhyay A
BMC Bioinformatics; 2017 Dec; 18(1):579. PubMed ID: 29262769
[TBL] [Abstract][Full Text] [Related]
36. Network-based approach to identify molecular signatures and therapeutic agents in Alzheimer's disease.
Rahman MR; Islam T; Turanli B; Zaman T; Faruquee HM; Rahman MM; Mollah MNH; Nanda RK; Arga KY; Gov E; Moni MA
Comput Biol Chem; 2019 Feb; 78():431-439. PubMed ID: 30606694
[TBL] [Abstract][Full Text] [Related]
37. Identification of Differentially Expressed Genes through Integrated Study of Alzheimer's Disease Affected Brain Regions.
Puthiyedth N; Riveros C; Berretta R; Moscato P
PLoS One; 2016; 11(4):e0152342. PubMed ID: 27050411
[TBL] [Abstract][Full Text] [Related]
38. Integrated analysis and network pharmacology approaches to explore key genes of Xingnaojing for treatment of Alzheimer's disease.
Wang M; Wang S; Li Y; Cai G; Cao M; Li L
Brain Behav; 2020 Jun; 10(6):e01610. PubMed ID: 32304290
[TBL] [Abstract][Full Text] [Related]
39. Sex-Stratified Single-Cell RNA-Seq Analysis Identifies Sex-Specific and Cell Type-Specific Transcriptional Responses in Alzheimer's Disease Across Two Brain Regions.
Belonwu SA; Li Y; Bunis D; Rao AA; Solsberg CW; Tang A; Fragiadakis GK; Dubal DB; Oskotsky T; Sirota M
Mol Neurobiol; 2022 Jan; 59(1):276-293. PubMed ID: 34669146
[TBL] [Abstract][Full Text] [Related]
40. Integrated DNA methylation and gene expression profiling across multiple brain regions implicate novel genes in Alzheimer's disease.
Semick SA; Bharadwaj RA; Collado-Torres L; Tao R; Shin JH; Deep-Soboslay A; Weiss JR; Weinberger DR; Hyde TM; Kleinman JE; Jaffe AE; Mattay VS
Acta Neuropathol; 2019 Apr; 137(4):557-569. PubMed ID: 30712078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
